INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia (Q48219674)

9 February 2018

http://europepmc.org/abstract/MED/25736236

title

INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia (English)

1 reference

9 February 2018

http://europepmc.org/abstract/MED/25736236

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Leonardo Salmena

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

I Dzneladze

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

R He

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M H Son

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M H Sharobim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

S A Greenberg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M Gabra

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

C Langlois

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Rashid

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Hakem

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

N Ibrahimova

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Arruda

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

B Löwenberg

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

P J M Valk

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M D Minden

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

4 March 2015

1 reference

9 February 2018

http://europepmc.org/abstract/MED/25736236

published in

Leukemia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

1485-1495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25736236%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

cites work

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Anthracycline dose intensification in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Resistance prediction in AML: analysis of 4601 patients from MRC/NCRI, HOVON/SAKK, SWOG and MD Anderson Cancer Center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Phosphoinositides: tiny lipids with giant impact on cell regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II. Evidence for conserved alternative splicing in the 4-phosphatase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Inositol polyphosphate 4-phosphatase II regulates PI3K/Akt signaling and is lost in human basal-like breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

A tumor suppressor function for the lipid phosphatase INPP4B in melanocytic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Alterations of INPP4B, PIK3CA and pAkt of the PI3K pathway are associated with squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Comprehensive molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

A genetic screen for candidate tumor suppressors identifies REST

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Phosphatidylinositol 4-phosphatase type II is an erythropoietin-responsive gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Classification of pediatric acute lymphoblastic leukemia by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

New prognostic markers in acute myeloid leukemia: perspective from the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

High Affinity Binding of Inositol Phosphates and Phosphoinositides to the Pleckstrin Homology Domain of RAC/Protein Kinase B and Their Influence on Kinase Activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2015.51

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25736236

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25736236